Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4–HLA-DR1 complex

Helper T-cell activation generally requires the coreceptor CD4, which binds MHC class II molecules. A remarkable feature of the CD4–MHC class II interaction is its exceptionally low affinity, which ranges from KD = ∼200 μM to >2 mM. Investigating the biological role of the much lower affinity of this interaction than those of other cell–cell recognition molecules will require CD4 mutants with enhanced binding to MHC class II for testing in models of T-cell development. To this end, we used in vitro-directed evolution to increase the affinity of human CD4 for HLA-DR1. A mutant CD4 library was displayed on the surface of yeast and selected using HLA-DR1 tetramers or monomers, resulting in isolation of a CD4 clone containing 11 mutations. Reversion mutagenesis showed that most of the affinity increase derived from just two substitutions, Gln40Tyr and Thr45Trp. A CD4 variant bearing these mutations bound HLA-DR1 with KD = 8.8 μM, compared with >400 μM for wild-type CD4. To understand the basis for improved affinity, we determined the structure of this CD4 variant in complex with HLA-DR1 to 2.4 Å resolution. The structure provides an atomic-level description of the CD4-binding site on MHC class II and reveals how CD4 recognizes highly polymorphic HLA-DR, -DP, and -DQ molecules by targeting invariant residues in their α2 and β2 domains. In addition, the CD4 mutants reported here constitute unique tools for probing the influence of CD4 affinity on T-cell activation and development.

[1]  Ellis L. Reinherz,et al.  Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[3]  B K Jakobsen,et al.  T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.

[4]  Ellis L. Reinherz,et al.  T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4* , 2001, The Journal of Biological Chemistry.

[5]  H. Wolfson,et al.  Shape complementarity at protein–protein interfaces , 1994, Biopolymers.

[6]  W A Hendrickson,et al.  Energetics of the HIV gp120-CD4 binding reaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Margulies,et al.  Structural Basis of the CD8αβ/MHC Class I Interaction: Focused Recognition Orients CD8β to a T Cell Proximal Position12 , 2009, The Journal of Immunology.

[8]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[9]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[10]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[11]  Mark M. Davis,et al.  Direct observation of ligand recognition by T cells , 2002, Nature.

[12]  V. Taneja,et al.  HLA class II transgenic mice mimic human inflammatory diseases. , 2008, Advances in immunology.

[13]  P. Marrack,et al.  T cell tolerance by clonal elimination in the thymus , 1987, Cell.

[14]  J. Sidney,et al.  Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells. , 2010, Journal of molecular biology.

[15]  Simon J Davis,et al.  Molecular interactions mediating T cell antigen recognition. , 2003, Annual review of immunology.

[16]  P. Anton van der Merwe,et al.  The nature of molecular recognition by T cells , 2003, Nature Immunology.

[17]  Mark M Davis,et al.  T cells as a self-referential, sensory organ. , 2007, Annual review of immunology.

[18]  D. Vignali,et al.  Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules , 1992, The Journal of experimental medicine.

[19]  C. Goodnow,et al.  Cellular and genetic mechanisms of self tolerance and autoimmunity , 2005, Nature.

[20]  Andrew K. Sewell,et al.  Human TCR-Binding Affinity is Governed by MHC Class Restriction1 , 2007, The Journal of Immunology.

[21]  Jia huai Wang,et al.  Protein recognition by cell surface receptors: physiological receptors versus virus interactions. , 2002, Trends in biochemical sciences.

[22]  A. Bogan,et al.  Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.

[23]  S. Smith‐Gill,et al.  Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces. , 2005, Structure.

[24]  C. Janeway.  The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. , 1992, Annual review of immunology.

[25]  E. Goldman,et al.  A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. , 1998, Biochemistry.

[26]  K Dane Wittrup,et al.  Yeast surface display for protein engineering and characterization , 2007, Current Opinion in Structural Biology.

[27]  P. A. Peterson,et al.  CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes , 1996, Nature.